Last reviewed · How we verify

NCT04128839

Impacts of Aronia on Inflammation and the Gut Microbiome

Completed NA Last updated 16 January 2024
What this trial tests

NA trial testing Aronia berry juice in Metabolic Syndrome in 40 participants. Completed in 27 December 2021.

Timeline
27 April 2019
Primary endpoint
30 September 2019
27 December 2021

Quick facts

Lead sponsorMontana State University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment40
Start date27 April 2019
Primary completion30 September 2019
Estimated completion27 December 2021
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Montana State University

Who can join

Adults 18 to 55, any sex, with Metabolic Syndrome or Inflammation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The overall goal of this project is to determine the inflammation lowering impact of anthocyanin-rich Aronia berries. Inflammation is an underlying mechanism driving the development of several diseases. While an elevation in immune signals in the systemic circulation is commonly attributed to adipose tissue, inflammation is not present in all obese individuals. Adipose tissue must become inflamed, and the inflammation trigger may come from other sources. Microorganisms (microbiome), host tissues, and immune cells residing in the gastrointestinal tract (GIT) are a key source of pro-inflammatory signals that may cause the host organism to become inflamed. Anthocyanins are bioactive compounds with established anti-inflammatory and microbiome altering properties. We hypothesize that the GIT microbiome is a key determinant of host inflammation than can be manipulated by anthocyanins-rich berries to lower inflammation. We assembled a cohort of individuals, characterized their GIT microbiome and performed anthropometric measurements, basal measures of metabolism and metabolic health, and triglyceridemic, metabolomic, and inflammation responses to a high-fat meal challenge.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Determinants of the postprandial triglyceride response to a high-fat meal in healthy overweight and obese adults.
    Wilson SM, Maes AP, Yeoman CJ, Walk ST, et al · · 2021 · cited 14× · PMID 34544430 · DOI 10.1186/s12944-021-01543-4
  2. Metabolic impact of polyphenol-rich aronia fruit juice mediated by inflammation status of gut microbiome donors in humanized mouse model.
    Wilson SMG, Peach JT, Fausset H, Miller ZT, et al · · 2023 · cited 7× · PMID 37727634 · DOI 10.3389/fnut.2023.1244692
  3. Temporal metabolic response yields a dynamic biosignature of inflammation.
    Peach JT, Wilson SM, Gunderson LD, Frothingham L, et al · · 2021 · cited 7× · PMID 34355150 · DOI 10.1016/j.isci.2021.102817
  4. Determinants of the Postprandial Triglyceride Response to a High-fat Meal in Healthy Overweight and Obese Adults.
    Wilson SM, Maes AP, Yeoman CJ, Walk ST, et al · · 2021 · DOI 10.21203/rs.3.rs-617713/v1

Verify or expand the search:

Other recruiting trials for Metabolic Syndrome

Currently open trials in the same condition.

Other Montana State University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04128839.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing